Skip to main content

Advertisement

Log in

Adverse effects of deoxycholic acid in submandibular glands, submental, inguinal and subplantar regions: a study in rats

  • Original Article
  • Published:
Clinical Oral Investigations Aims and scope Submit manuscript

Abstract

Objective

We aimed to evaluate the effects of the deoxycholic acid (DCA) in the submental and subplantar regions of rats, and to histologically analyze the changes caused in the submandibular glands, soft tissues of the paw, and inguinal adipose tissue.

Material and methods

Sixty male Wistar rats were divided into DCA and control (CG) groups. DCA was injected in the submental, inguinal, and subplantar regions, and saline was injected in the CG. The animals were euthanized after 24 h and at 7 and 21 days.

Results

The DCA group showed edema in the submental region in 24 h and in the paw in all experimental times. In the paw there were also erythema and ulceration in 7 days, and alopecia after 21 days. At 21 days, a few animals also showed erythema and ulceration in paw; however, there was no significant difference from CG. Histological analysis of the paw showed an intense inflammatory process, with a predominance of neutrophils, lymphocytes, and plasma cells in 24 h and 7 days. In the adipose tissue, we observed loss of architecture and inflammatory infiltrate, followed with a lower number of adipose cells, and at 21 days, fibroplasia. In the submandibular glands we observed inflammatory infiltration, loss of tissue architecture, and fibrosis.

Conclusions

DCA produces a significant inflammatory process in the structures. It can cause skin ulcerations and, in salivary glands, it causes loss of tissue architecture and fibrosis.

Clinical relevance

There has been growing increase in the use of DCA for aesthetic purposes by health care providers. Due to the presence of important anatomical structures in the submental region, constant vigilance is required to report new adverse effects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Ascher B, Fellmann J, Monheit G (2016) ATX-101 (deoxycholic acid injection) for reduction of submental fat. Expert Rev Clin Pharmacol 9:1131–1143. https://doi.org/10.1080/17512433.2016.1215911

    Article  PubMed  Google Scholar 

  2. Rotunda AM, Weiss SR, Rivkin LS (2009) Randomized double-blind clinical trial of subcutaneously injected deoxycholate versus a phosphatidylcholine-deoxycholate combination for the reduction of submental fat. Dermatologic Surg 35:792–803. https://doi.org/10.1111/j.1524-4725.2009.01130.x

    Article  Google Scholar 

  3. Dayan SH, Humphrey S, Jones DH et al (2016) Overview of ATX-101 (deoxycholic acid injection): a nonsurgical approach for reduction of submental fat. Dermatologic Surg 42:S263–S270. https://doi.org/10.1097/DSS.0000000000000870

    Article  Google Scholar 

  4. Dunican KC, Patel DK (2016) Deoxycholic acid (ATX-101) for reduction of submental fat. Ann Pharmacother 50:855–861. https://doi.org/10.1177/1060028016653966

    Article  PubMed  Google Scholar 

  5. Zarbafian M, Karavan M, Greene R, Fabi SG (2020) Efficacy and safety of ATX-101 as a treatment for submental fullness: a retrospective analysis of two aesthetic practices. J Cosmet Dermatol 19:1328–1332. https://doi.org/10.1111/jocd.13165

    Article  PubMed  Google Scholar 

  6. Behr K, Kavali CM, Munavalli G et al (2020) ATX-101 (deoxycholic acid injection) leads to clinically meaningful improvement in submental fat: final data from contour. Dermatol Surg 46:639–645. https://doi.org/10.1097/DSS.0000000000002092

    Article  PubMed  Google Scholar 

  7. Grady B, Porphirio F, Rokhsar C (2017) Submental alopecia at deoxycholic acid injection site. Dermatol Surg 43:1105–1108. https://doi.org/10.1097/DSS.0000000000001085

    Article  PubMed  Google Scholar 

  8. Lindgren AL, Welsh KM (2019) Inadvertent intra‐arterial injection of deoxycholic acid: a case report and proposed protocol for treatment. J Cosmet Dermatol 1–5.https://doi.org/10.1111/jocd.13214

  9. Dayan SH, Schlessinger J, Beer K et al (2018) Efficacy and safety of ATX-101 by treatment session: pooled analysis of data from the phase 3 REFINE trials. Aesthetic Surg J 38:998–1010. https://doi.org/10.1093/asj/sjy008

    Article  Google Scholar 

  10. Georgesen C, Lipner SR (2017) The development, evidence, and current use of ATX-101 for the treatment of submental fat. J Cosmet Dermatol 16:174–179. https://doi.org/10.1111/jocd.12347

    Article  PubMed  Google Scholar 

  11. Walker P, Lee D (2015) A phase 1 pharmacokinetic study of ATX-101: serum lipids and adipokines following synthetic deoxycholic acid injections. J Cosmet Dermatol 14:33–39. https://doi.org/10.1111/jocd.12122

    Article  PubMed  Google Scholar 

  12. Humphrey S, Sykes J, Kantor J et al (2016) ATX-101 for reduction of submental fat: a phase III randomized controlled trial. J Am Acad Dermatol 75:788-797.e7. https://doi.org/10.1016/j.jaad.2016.04.028

    Article  PubMed  Google Scholar 

  13. Rotunda AM, Ablon G, Kolodney MS (2005) Lipomas treated with subcutaneous deoxycholate injections. J Am Acad Dermatol 53:973–978. https://doi.org/10.1016/j.jaad.2005.07.068

    Article  PubMed  Google Scholar 

  14. Schuller-Petrovic S, Wölkart G, Höfler G et al (2008) Tissue-toxic effects of phosphatidylcholine/deoxycholate after subcutaneous injection for fat dissolution in rats and a human volunteer. Dermatologic Surg 34:529–543. https://doi.org/10.1111/j.1524-4725.2008.34128.x

    Article  Google Scholar 

  15. Park SH, Hyun MR, Kim SW (2019) Effect of a formulation containing low-dose sodium deoxycholate on local fat reduction. Aesthetic Plast Surg 43:1657–1662. https://doi.org/10.1007/s00266-019-01514-2

    Article  PubMed  Google Scholar 

  16. Kenkel JM, Jones DH, Fagien S et al (2016) Anatomy of the cervicomental region. Dermatologic Surg 42:S282–S287. https://doi.org/10.1097/DSS.0000000000000896

    Article  Google Scholar 

  17. Larson JD, Tierney WS, Ozturk CN, Zins JE (2014) Defining the fat compartments in the neck: a cadaver study. Aesthetic Surg J 34:499–506. https://doi.org/10.1177/1090820X14526406

    Article  Google Scholar 

  18. Noh Y, Heo C (2012) The effect of phosphatidylcholine and deoxycholate compound injections to the localized adipose tissue: an experimental study with a murine model. Arch Plast Surg 39:452–456. https://doi.org/10.5999/aps.2012.39.5.452

    Article  PubMed  PubMed Central  Google Scholar 

  19. Chung SJ, Lee CH, Lee HS et al (2014) The role of phosphatidylcholine and deoxycholic acid in inflammation. Life Sci 108:88–93. https://doi.org/10.1016/j.lfs.2014.05.013

    Article  PubMed  Google Scholar 

  20. El-Gowelli HM, El Sabaa B, Yosry E, El-Saghir H (2016) Histopathological and ultra-structural characterization of local neuromuscular damage induced by repeated phosphatidylcholine/deoxycholate injection. Exp Toxicol Pathol 68:39–46. https://doi.org/10.1016/j.etp.2015.09.006

    Article  PubMed  Google Scholar 

  21. Silva ML, Tasso L, Azambuja AA et al (2017) Effect of hyperbaric oxygen therapy on tooth extraction sites in rats subjected to bisphosphonate therapy—histomorphometric and immunohistochemical analysis. Clin Oral Investig 21:199–210. https://doi.org/10.1007/s00784-016-1778-3

    Article  PubMed  Google Scholar 

  22. Maahs MP, Azambuja AA, Campos MM et al (2011) Association between bisphosphonates and jaw osteonecrosis: a study in Wistar rats. Head Neck 33:199–207. https://doi.org/10.1002/hed.21422

    Article  PubMed  Google Scholar 

  23. Duncan D, Rotunda AM (2011) Injectable therapies for localized fat loss: state of the art. Clin Plast Surg 38:489–501. https://doi.org/10.1016/j.cps.2011.02.005

    Article  PubMed  Google Scholar 

  24. Fagien S, McChesney P, Subramanian M, Jones DH (2016) Prevention and management of injection-related adverse effects in facial aesthetics: considerations for ATX-101 (deoxycholic acid injection) treatment. Dermatol Surg 42:S300–S304

    Article  Google Scholar 

  25. Shridharani SM, Chandawarkar AA (2019) Novel expanded safe zone for reduction of submental fullness with ATX-101 injection. Plast Reconstr Surg 144:995e–1001e. https://doi.org/10.1097/PRS.0000000000006299

    Article  PubMed  Google Scholar 

  26. Mroz MS, Lajczak XNK, Goggins BJ et al (2018) The bile acids, deoxycholic acid and ursodeoxycholic acid, regulate colonic epithelial wound healing. Am J Physiol Liver Physiol 314:G378–G387. https://doi.org/10.1111/jocd.13165

    Article  Google Scholar 

  27. Sebaratnam DF, Wong XL, Kim L, Cheung K (2019) Alopecia following deoxycholic acid treatment for submental adiposity. JAMA Facial Plast Surg 21:571. https://doi.org/10.1001/jamafacial.2019.0640

    Article  PubMed  Google Scholar 

  28. Souyoul S, Gioe O, Emerson A, Hooper DO (2017) Alopecia after injection of ATX-101 for reduction of submental fat. JAAD Case Rep 3:250–252. https://doi.org/10.1016/j.jdcr.2017.02.021

    Article  PubMed  PubMed Central  Google Scholar 

  29. Rotunda AM, Suzuki H, Moy RL, Kolodney MS (2004) Detergent effects of sodium deoxycholate are a major feature of an injectable phosphatidylcholine formulation used for localized fat dissolution. Dermatol Surg 30:1001–1008. https://doi.org/10.1111/j.1524-4725.2004.30305.x

    Article  PubMed  Google Scholar 

  30. Thuangtong R, Bentow JJ, Knopp K et al (2010) Tissue-selective effects of injected deoxycholate. Dermatol Surg 36:899–908. https://doi.org/10.1111/j.1524-4725.2010.01566.x

    Article  PubMed  Google Scholar 

Download references

Funding

This work was supported by Coordenação de Aperfeiçoamento de Pessoal de Nível Superior-Brasil (CAPES) finance code 001.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Fernanda Gonçalves Salum.

Ethics declarations

Ethics approval

The study was approved by the Scientific Committee of the School of Health and Life Sciences of Pontifical Catholic University of Rio Grande do Sul (PUCRS), Brazil and by the Ethics Committee on Animals Use (CEUA) of the same institution (PUCRS, protocol number 9073).

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Farina, G.A., Koth, V.S., Maito, F.L.d.M. et al. Adverse effects of deoxycholic acid in submandibular glands, submental, inguinal and subplantar regions: a study in rats. Clin Oral Invest 26, 2575–2585 (2022). https://doi.org/10.1007/s00784-021-04227-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00784-021-04227-6

Keyword

Navigation